Atypical teratoid/ rhabdoid tumor of brain: a clinicopathologic study of eleven patients and review of literature by Ud Din, Nasir et al.
eCommons@AKU
Department of Pathology and Laboratory Medicine Medical College, Pakistan
April 2017
Atypical teratoid/ rhabdoid tumor of brain: a
clinicopathologic study of eleven patients and
review of literature
Nasir Ud Din
Aga Khan University, nasir.uddin@aku.edu
Abrar Barakzai
Aisha Memon
aisha.memon@aku.edu
Sheema Hasan
Aga Khan University, sheema.hasan@aku.edu
Zubair Ahmad
Aga Khan University, zubair.ahmad@aku.edu
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_pathol_microbiol
Part of the Microbiology Commons, and the Pathology Commons
Recommended Citation
Ud Din, N., Barakzai, A., Memon, A., Hasan, S., Ahmad, Z. (2017). Atypical teratoid/ rhabdoid tumor of brain: a clinicopathologic
study of eleven patients and review of literature. Asian Pacific Journal of Cancer Prevention, 18(4), 949-954.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/769
Asian Pacific Journal of Cancer Prevention, Vol 18 949
DOI:10.22034/APJCP.2017.18.4.949
Atypical Teratoid/Rhabdoid Tumor 
Asian Pac J Cancer Prev, 18 (4), 949-954
Introduction
Atypical Teratoid/rhabdoid tumor (AT/RT) is defined 
as a malignant central nervous system (CNS) embryonal 
tumor composed predominantly of poorly differentiated 
elements frequently with rhabdoid cells and inactivation 
of SMARCB1(INI 1) or extremely rarely SMARCA4 
(BAG1). (Judkins et al, 2016) Atypical Teratoid/Rhabdoid 
Tumor (AT/RT) is a rare, highly malignant and aggressive 
CNS neoplasm which mostly occurs in infants and young 
children under the age of 3 years (mean age approximately 
2 years). It is very rare in children older than 6 years; 
however occasional cases occur in adults. It is more 
common in males (male to female ratio 1.6 to 2.0 :1.0). 
(Hilden et al., 2004;Raisanen et al., 2005;Judkins et al., 
2007; Makuria et al., 2008) It mostly occurs in the cerebral 
and cerebellar hemispheres, cerebellopontine angle and 
brain stem; spinal examples are exceedingly rare. (Yang 
et al., 2007) Especially in infants, signs and symptoms are 
non-specific and include lethargy, vomiting and failure to 
thrive. (Judkins et al., 2007) AT/RT commonly seeds via 
the cerebrospinal fluid pathways. Findings on CT and MRI 
are similar to those seen in medulloblastoma and tumors 
previously designated as CNS PNETs. Almost all AT/RTs 
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Background: Atypical teratoid/ rhabdoid tumor (AT/RT) is a rare aggressive embryonal central nervous system 
(CNS) tumor of infancy and early childhood. Majority of the cases arise in the posterior fossa, and remaining in the 
cerebrum. Aims: To analyze the clinicopathologic features of AT/RT on a cohort of cases. Materials and methods: 
All reported cases of AT/RT at the Department of Pathology and Laboratory Medicine, Aga Khan University Hospital 
(AKUH) from 2007 to 2016 were reviewed for clinical and pathological features. Immunohistochemical stain for INI-1 
was performed in all 11 cases. Follow up was obtained. Results: A total of 11 cases were identified. Seven patients were 
males and 4 were females. The ages ranged from 1 month to 48 months (mean 26.6 months). Six tumors were located 
in the cerebrum and 3 in the posterior fossa. Exact Location was not known in 2 cases. Histologically, rhabdoid cells 
were present in sheets in variable proportions in five cases, Medulloblastoma and PNET like areas were seen in 2 cases 
each. Immunohistochemical stains EMA (10/10), vimentin (7/7), CKAE1/AE3 (8/9), and CD99 (3/4), GFAP (6/10), 
ASMA (3/4) and synaptophysin (3/4) were positive in varying proportions while desmin was negative in all 6 cases in 
which it was performed. All 11 tumors lacked immunoreactivity for INI-1 protein. Four patients died of disease with 
a follow up ranging from 5 to 24 months. Conclusions: AT/RT is a rare highly aggressive embryonal tumor of CNS. 
A male predominance was noted in our series. We report the first and largest series from Pakistan.
Keywords: Atypical teratoid/rhabdoid tumor- posterior fossa- cerebrum- INI 1
RESEARCH ARTICLE
Atypical Teratoid/ Rhabdoid Tumor of Brain: a Clinicopathologic 
Study of Eleven Patients and Review of Literature
Nasir Ud Din1*, Abrar Barakzai2, Aisha Memon1, Sheema Hasan1, Zubair Ahmad1
are contrast enhancing, and leptomeningeal dissemination 
is seen in almost 25% cases at the time of presentation. 
(Meyers et al., 2006) Macroscopically, AT/RT is large in 
size, soft and fleshy in consistency, with necrotic areas. 
On histology, usually a complex histologic pattern is seen 
due to combination of rhabdoid, primitive neuroepithelial, 
epithelial and mesenchymal components. These divergent 
histologic patterns sometimes results in misdiagnosis of 
AT/RT as medulloblastoma, CNS PNET, choroid plexus 
carcinoma etc. In the past, it was mostly reported as 
medulloblastoma or PNET. Loss of immunohistochemical 
expression of INI-1 protein is sensitive and specific and a 
reliable diagnosis is not possible without demonstrating 
loss of INI-1 CNS protein expression. (Judkins et al., 2007; 
Makuria et al., 2008) AT/RT corresponds to WHO grade 
IV, and demonstrates a marked proliferative (Mib 1/Ki-67) 
index usually more than 50%. (Ho et al., 2000) Its genetic 
hallmark is mutation or loss of INI 1(hSNf5/SMARC B1) 
locus at 22q11.2. (Biegel et al.,  2000)  Prognosis is dismal, 
most patients die soon after diagnosis. Various studies 
have reported mean survival times ranging from 11 to 24 
months. (Hilden et al., 2004; Chen et al., 2005; Burger 
et al., 1998) Prognosis is better in patients older than 3 
years; and in the rare adults cases, long term survival 
1Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan, 2Department of Pathology, 
College of Medicine Alfaisal University, Riyadh, Saudi Arabia. *For Correspondence: nasir.uddin@aku.edu
Nasir Ud Din et al
Asian Pacific Journal of Cancer Prevention, Vol 18950
may be possible after surgery, adjuvant radiotherapy and 
chemotherapy.(Makuria et al., 2008;Takautz et al., 2005)
The Section of Histopathology at the Aga Khan 
University Hospital, Karachi is the largest center for 
histopathology in Pakistan. CNS tumors are common 
in practice (Ahmad et al., 2011; Ahmad et al., 2016). 
We diagnosed our first case of AT/RT in 2004. Here, we 
present a series of 11 cases of AT/RT that were reported 
by us.
Materials and Methods
Eleven cases reported as AT/RT between 2004 and 
2016 were retrieved from the surgical pathology files 
of the Section of Histopathology, Aga Khan University 
(AKU). All 11 patients had been operated outside AKUH 
and tissue (or blocks in 2 cases) was sent to us for 
histopathological examination. All specimens had been 
fixed in 10% buffered formalin, embedded in paraffin 
wax and paraffin sections were cut at a thickness of 3um 
on a routine microtome. The sections were routinely 
stained with Hematoxylin and Eosin (H and E). Formalin 
fixed, paraffin embedded tissue sections were cut at 3 
μm for immunohistochemical studies. Sections were 
deparaffinized, rehydrated and moistened with running 
tap water. The sections were pretreated in a microwave 
oven at 800W for 20 minutes with target retrieval 
solution at high pH (heat induced epitope retrieval 
or HIER). The sections were incubated with primary 
antibodies on an automated immunostaining system for 
30 minutes at room temperature (DAKO autostainer 
plus, Glostrup, Denmark). Immunohistochemical 
staining was performed with the ready to use (RTU) 
Envision system using the following antibodies: 
Desmin (Dako, Glostrup, Denmark, monoclonal, 
dilution 1:100); CD99 (Dako, monoclonal, 1:50); 
Cytokeratin(CK) AE1/AE3 (Dako,monoclonal,1:400); 
GFAP (Dako,monoclonal, 1:100); Smooth muscle 
actin (SMA, Dako, monoclonal,1:150); S100 protein 
(polyclonal, Dako,1:300), epithelial membrane antigen 
(EMA, Dako, monoclonal,1:100),synaptophysin (Dako, 
monoclonal, 1:50); Chromogranin A (Dako, monoclonal, 
1:200); Vimentin (Dako, monoclonal,1:120); CD99 (Dako, 
monoclonal, 1:50); Neurofilament (Dako,monoclonal, 
1:100). As INI 1 was previously not available in our 
section, paraffin blocks were sent to Hospital for Sick 
Children,Toronto, Canada, where INI 1 immunostaining 
(Santa Cruz; Santacruz, CA, USA,1:50) was performed. 
However, INI 1 antibody was acquired in late 2014, and in 
the last 2 cases (diagnosed in 2015 & 2016 respectively), 
INI 1 was performed in our section. Molecular tests for 
inactivation of SMARCB1 and SMARCA4 were not 
available and were not performed.
Epidemiological data such as age of patient, gender, 
site of tumor, clinical signs and symptoms, survival time 
following diagnosis etc was recorded.
The slides of all 11 cases were reviewed by the two 
principal authors (NU and ZA).
Results
Out of 11 patients, 7 were males and 4 were females, 
the age at presentation ranged from 1 month to 48 months 
(mean 26.6 months). Tumor location was posterior fossa in 
3 cases; frontoparietal and temporoparietal lobes in 2 cases 
each; frontal and temporoparietal lobes in 1 case each. In 
2 cases, exact location was not known. Radiology was 
available in 5 cases. Radiologically, CT and MRI showed 
bulky, slightly hyperintense and contrast enhancing lesions 
with cystic, necrotic and hemorrhagic areas. Gross size 
of resected tumor fragments ranged from 1 to 5 cms 
(mean 3.5cms) in maximum dimension. The clinical and 
morphological features(Figure 1A, B, Figure 2A-D) and 
follow up information (6 cases) of all 11 cases is shown 
in Table 1. Follow up was available in only 6 of 11 cases. 
Discussion
Clinical history in most of our cases was either not 
available or was vague and nonspecific. Radiological 
films were not available in majority of cases. We receive 
cases from all over Pakistan and even from neighboring 
Afghanistan. By an unfortunate coincidence, most of our 
11 cases came from remote areas (including one from 
Afghanistan) and contact with surgeons was not possible 
or proved difficult. The clinicians themselves were 
Figure 1: A) Mixture of Spindle and Epithelioid Tumor 
Cells and B) Sheets of Epithelioid Cells (H and E, 200x 
Magnification) 
Figure 2. Immunohistochemical Expression of AT/RT. 
the Tumor Cells Showed Positivity for Cytokeratin AE1/
AE3 (A), EMA (B) and Vimentin (C). There is Loss of 
Expression of INI 1 (D)
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22q deletions and alterations of INI 1/hSNF5 gene. 
Other studies focused more on the chromosomal and 
genetic alterations which are seen not only in AT/RT in 
children. (Lee et al., 2002) but also in adults (Raisanen 
et al., 2005) However, these studies also emphasized that 
chromosome 22 alterations, although useful diagnostic 
markers of AT/RT, were not present in all cases. (Wharton 
et al., 2003; Biegel, 2006) Other studies at the time and 
later studied the prognostic and therapeutic factors and 
showed that aggressive therapy (chemotherapy, intrathecal 
chemotherapy, radiotherapy, stem cell rescue) prolong the 
natural history. (Hilden et al., 2004)
A study by Athale et al., (2009) demonstrated that 
craniospinal spread was the major cause of death in 
AT/RT and that intrathecal chemotherapy resulted in a 
significantly higher two year overall survival (OS) and 
lower prevalence of distant CNS metastasis, and they 
argued in favour of multimodal therapy and especially 
intrathecal chemotherapy. A recent study by Dufour et al., 
(2012) looked at the clinicopathologic prognostic factors 
in childhood AT/RT and concluded that the prognosis was 
dismal. They identified age less than 2 year, metastasis 
at diagnosis, and strong diffuse immunopositivitys for 
claudin 6 as independent prognostic factors for increased 
risk of death. Most recent studies have also demonstrated 
the importance of SMARCB1/INI 1 genetic alterations on 
chromosome 22 in AT/RT which lead to loss of SMARCB1/
INI 1 protein expression. However, occasionally such 
loss may not occur and conversely such losses may 
also be occasionally seen in choroid plexus carcinoma. 
(Schittenhelm et al., 2011; Hasselblatt et al., 2012; 
Hasselblatt et al., 2012) Indeed, distinguishing AT/RT with 
predominant epithelial differentiation from choroid plexus 
carcinomas can be difficult since both occur in the same 
age group and have similar histopathological features. 
(Schittenhelm et al., 2011). In the majority of cases, even 
the clinical details were sketchy at best. In our addition, 
by an unfortunate coincidence, most of our 11 cases came 
from remote areas, where the clinicians were mostly 
unaware of AT/RT and the therapeutic tools (limited in 
even major cities) were unavailable. Indeed, only 2 out of 
our 11 patients received chemotherapy and that too only 
when the tumor recurred. In all probability, the tumor had 
not been completely excised in any of the 11 unfortunate 
patients. We acquired the INI 1 immunohistochemical 
stain in 2014. However, we still do not have the molecular 
tests for AT/RT (the extreme rarity of the tumor makes this 
financially unfeasible in a general histopathology center 
and a specialized neuropathology center in Pakistan may 
still be years away. According to the 2016 CNS WHO 
update, in tumors corresponding to morphology of AT/
RT but in which the expression of SMARCB1(INI 1) 
and SMARCA4(BRG1)could not be confirmed should 
be diagnosed as “CNS embryonal tumors with rhabdoid 
features”. (Judkins, et al., 2016) We believe that this 
present series of 11 cases will raise awareness about AT/
RT in Pakistan among histopathologists, neurosurgeons, 
medical and radiation oncologists and lead to better 
recognition, early diagnosis and more optimum treatment 
in the near future.
mostly unaware of this tumor entity. In all probability, 
all 11 patients underwent subtotal resection. Out of 
6 patients in whom follow up was available, parents 
refused chemotherapy (a common scenario in remote, 
less developed areas of the country) and radiotherapy in 
2 cases (patients 5 and 6). Other cases (patients 7 and 10), 
chemotherapy and radiotherapy were planned but patients 
died before these could be started. In 1 case (patient 4), 
chemo and radiotherapy were given after patient developed 
recurrence three months after surgery. In the remaining 1 
case (patient 11), 1 cycle of chemotherapy (anthracycline 
based) and radiation were given but patient died about 6 
months after surgery.   Mean age of patients at diagnosis 
was 26.6 months in our series. Hilden et al.(Hilden et 
al., 2004) reported mean age at diagnosis of 24 months. 
Seven of our 11 patients were males. Schittenhelm et 
al.(Schittenhelm et al., 2011) also reported preponderance 
in males under 3 years of age. Even in adults affected by 
AT/RT, males were predominantly affected. (Makuria 
et al., 2008) We have, to date not reported any case 
in adults. Erickson et al. reported a case in a pregnant 
female. (Erickson et al., 2005) To our knowledge, these 11 
cases are the first reported cases of AT/RT from Pakistan, 
although there are three studies from neighboring India.
(Bansal and Goel, 2007; Biswas et al.,2009; Biswas et 
al.,2015) All 5 patients in Biswas et al’s original study 
(Biswas et al.,2009) were males; 3 out of 5 cases were 
infratentorial (in posterior fossa) and 2 were supratentorial 
(in frontoparietal and frontotemporal lobes). In their 
recent study (Biswas et al., 2015), male to female ratio 
was 4:1, median age at presentation was 5 years while 
tumor location was supratentorial and infratentorial in 
60% and 40% cases respectively. In this study, Biswas 
et al demonstrated that maximal safe resection followed 
by craniospinal irradiation and systemic chemotherapy 
with ICE (ifosfamide, carboplatin, etoposide) and VAC 
(vincristine, dactinomycin,cyclophosphamide) is an 
effective treatment strategy for these aggressive tumors. 
In our study, 3 cases were infratentorial (posterior fossa) 
and 6 cases were supratentorial (see results).
Although AT/RT has been shown to comprise 1-2% 
of childhood brain tumors (Wong et al., 2005; Rickert 
and Paulus, 2001), and is now increasingly recognized, 
most published data about this entity still remains based 
on case reports and case series. A number of case reports 
have been published on AT/RT from Asia especially the 
Far East. (Lee et al., 2004; Yang et al., 2007; Rehmat et 
al., 2008) Other case reports have described AT/RT arising 
in unusual sites such as spine (Yang et al., 2007), pineal 
region (Taki et al., 2010) and the third cranial nerve. 
(Wykoff et al., 2008) Reports of AT/RT in adults continue 
to be published. (Erickson et al., 2005;Makuria et al., 
2008; Taki et al., 2010; Samaras et al., 2009) In the early 
years of the new century, several studies were published 
on the clinicopathological and radiological features of AT/
RT (Bambakidis et al., 2002; Lee et al., 2002; Packer et 
al., 2002), which described these features and highlighted 
that diagnosis of AT/RT was based on distinctive light 
microscopic and immunohistochemical findings together 
with molecular genetic analysis especially chromosome 
Nasir Ud Din et al
Asian Pacific Journal of Cancer Prevention, Vol 18954
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